Triomics' generative AI startup raised $15M for automating cancer clinical trial matching with OncoLLM™.
Triomics, a generative AI startup, raised $15M in Series A funding to automate cancer clinical trials matching for patients. The platform uses OncoLLM™, a specialized AI model, to help cancer providers process health record data at scale, match patients to clinical trials, and improve quality of care operations. With this funding, Triomics aims to expand operations and development efforts to streamline cancer center workflows.
May 09, 2024
4 Articles